Pre-treatment antibiotic dip may deter post-penile implant infection

Article

Results of a study comparing the in vitro antibacterial activity of antibiotic-dipped and non-antibiotic-dipped components of inflatable penile implants show differences favoring Titan implants dipped into antibiotic solutions of rifampin-gentamicin or bacitracin-gentamicin compared with the antibiotic (rifampin-minocycline)-coated technology of Inhibizone.

However, it remains to be determined whether these in vitro differences are clinically significant, said lead author Chirpriya B. Dhabuwala, MD, who conducted the study while a professor of urology at Wayne State.

Research from Dr. Dhabuwala's laboratory was the basis for the commercial introduction of antibiotic-coated penile implants. In 1998, Dr. Dhabuwala and colleagues reported results from studies they conducted in a rat model that showed coating silicone strips with rifampin and minocycline significantly reduced infections caused by Staphylococcus epidermidis.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.